Status:
RECRUITING
A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
Lead Sponsor:
Teleflex
Conditions:
Vascular Access Device
Eligibility:
All Genders
Brief Summary
The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular ...
Detailed Description
The primary objective is to provide high-quality Level 3 (or better), data as defined by Medical Device Coordination group (MDCG) 2020-6, on the performance, and clinical benefits of Teleflex's vascul...
Eligibility Criteria
Inclusion
- Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
- Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
- Subjects is able to read and understand English or Spanish languages
Exclusion
- Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
- Subject was previously failed screening or was enrolled in this clinical Registry.
- Subject is imprisoned
- Subject is cognitively impaired and unable to provide informed consent
Key Trial Info
Start Date :
December 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 7 2034
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06604039
Start Date
December 8 2024
End Date
December 7 2034
Last Update
August 7 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsville Hospital
Huntsville, Alabama, United States, 35801
2
Loma Linda University Health
Loma Linda, California, United States, 92354
3
Tufts Medical Center
Boston, Massachusetts, United States, 02111